|4Aug 22, 5:30 PM ET

Boenisch Sandra 4

4 · ANAVEX LIFE SCIENCES CORP. · Filed Aug 22, 2025

Insider Transaction Report

Form 4
Period: 2025-08-20
Boenisch Sandra
PFO & Treasurer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-08-20+12,50012,500 total
    Exercise: $8.58From: 2025-08-20Exp: 2035-03-31Common Stock (12,500 underlying)
Footnotes (1)
  • [F1]On March 31, 2025, the reporting person was granted an option to purchase 50,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which was Publication of preclinical blarcamesine prevention AD data. The performance criteria for this milestone was met, resulting in vesting of the option as to 12,500 shares.

Documents

1 file
  • 4
    ownership.xmlPrimary